Affimed N.V Ret. on equity
What is the Ret. on equity of Affimed N.V?
The Ret. on equity of Affimed N.V. is -48.04%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Affimed N.V
What does Affimed N.V do?
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Companies with ret. on equity similar to Affimed N.V
- Stemline Therapeutics has Ret. on equity of -48.14%
- Tele Columbus AG has Ret. on equity of -48.08%
- Mariner Resources has Ret. on equity of -48.07%
- Northstar Gold has Ret. on equity of -48.06%
- Hilton Worldwide Inc has Ret. on equity of -48.05%
- Jones Soda Co has Ret. on equity of -48.05%
- Affimed N.V has Ret. on equity of -48.04%
- Landcadia II has Ret. on equity of -48.03%
- Redline Communications has Ret. on equity of -48.00%
- Cravatex has Ret. on equity of -47.97%
- Aileron Therapeutics Inc has Ret. on equity of -47.94%
- Bubs Australia has Ret. on equity of -47.92%
- Revasum has Ret. on equity of -47.91%